CHIRAL CROTYLBORONATES: METHODOLOGY AND SYNTHESIS
手性巴豆基硼酸酯:方法学和合成
基本信息
- 批准号:3294876
- 负责人:
- 金额:$ 17.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-02-01 至 1996-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The efficient stereo- and enantioselective synthesis of complex arrays of
acyclic stereocenters constitutes one of the most intriguing challenges in
modern synthetic organic chemistry. The multitude of such acyclic arrays
in macrolides, polyether antibiotics, complex carbohydrates and numerous
other classes of biologically active natural products has provided
considerable stimulus for the development of synthetic methodology that is
practical, efficient, and applicable to a wide range of problems.
The major objectives of this research program continue to be (1) the
development of a family of highly enantioselective chiral allyl- and
crotylboronates and (2) the application of this technology in the synthesis
of biologically active, propionate-derived natural products. The tartrate
ester modified allylboronates 1-3 developed in our laboratory function
beautifully in matched double asymmetric reactions but often give less
satisfactory results in mismatched double asymmetric reactions.
Consequently, additional effort will be devoted to the development of
improved, second generation reagents 63 and 68-70. Our observation that
the % e.e. of the allylborations of unsaturated aldehydes is significantly
enhanced by using metal carbonyl complexes as substrate surrogates will be
applied in enantioselective syntheses of carbocyclin and of a key rutamycin
B intermediate (124). Syntheses of streptovaricin D and bafilomycin A1
initiated in the previous grant period will be completed, and syntheses of
zincophorin and rutamycin B will be initiated in the later years of this
grant. Methods for construction the unusual quinone methide unit of
streptovaricin D must be developed. A stereochemical study of the
reactions of gamma-methoxyallylchromium and chiral aldehydes will be
completed in connection with the bafilomycin synthesis, and additional
studies into the factors that control the stereochemistry of the
bafilomycin aldol coupling reaction (55 and 28) will be performed. Aldol
reactions for fragment assembly steps in the rutamycin synthesis also will
be examined. These studies provide the opportunity to define the
stereochemical preferences of the Lewis acid catalyzed aldol reactions of
enol silanes prepared from chiral alpha-methyl ketones, the results of
which will be of considerable significance particularly if substantial
selectivity is observed.
立体选择性和对映选择性合成的复杂阵列
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM R ROUSH其他文献
WILLIAM R ROUSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM R ROUSH', 18)}}的其他基金
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
癌症治疗中的靶向酪蛋白激酶 1d/e (CK1d/1e)
- 批准号:
8631767 - 财政年份:2014
- 资助金额:
$ 17.97万 - 项目类别:
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
癌症治疗中的靶向酪蛋白激酶 1d/e (CK1d/1e)
- 批准号:
8840911 - 财政年份:2014
- 资助金额:
$ 17.97万 - 项目类别:
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
癌症治疗中的靶向酪蛋白激酶 1d/e (CK1d/1e)
- 批准号:
9049453 - 财政年份:2014
- 资助金额:
$ 17.97万 - 项目类别:
SYNTHESIS OF INHIBITORS OF PARASITIC CYSTEINE PROTEASES
寄生半胱氨酸蛋白酶抑制剂的合成
- 批准号:
6338609 - 财政年份:2000
- 资助金额:
$ 17.97万 - 项目类别:
SYNTHESIS OF INHIBITORS OF PARASITIC CYSTEINE PROTEASES
寄生半胱氨酸蛋白酶抑制剂的合成
- 批准号:
6099783 - 财政年份:1999
- 资助金额:
$ 17.97万 - 项目类别: